AddedRisk Factors
Because AI and other emerging technologies are complex and rapidly evolving, we may not be able to fully anticipate or mitigate all associated risks. Implementing appropriate safeguards, controls, monitoring, and human oversight may be costly and time‑consuming and may not prevent all harms. If our AI initiatives do not perform as expected, fail to deliver anticipated efficiencies or insights, produce unreliable or biased results, or give rise to privacy, security, ethical, or legal concerns, our brand and customer trust could be harmed, and our profitability could be negatively impacted, and our competitive position could be weakened. Any of the foregoing could materially and adversely affect our business, results of operations, financial condition, and prospects.
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
RemovedRisk Factors
that disputes will not arise as to the sharing of the costs of such activity, which could impact our relationship with the distributors or impose additional costs on us.
Read it in 10-K Feb 26, 2025 at sec.govopen_in_new
RewordedRisk Factors
The amount of additional capital we may require, the timing of our capital needs and the availability of financing to fund those needs will depend on a number of factors, including our strategic initiatives and operating plans, the performance of our business, the number, complexity and characteristics of additional products or future manufacturing processes we require to serve new or existing markets, any proposed acquisitions and cost increases related to the integration of acquired products or businesses, any material or significant product recalls, any failure or disruption with our manufacturing and co-packing partners as well as our third party logistics providers, the expansion into new markets, any changes in our regulatory or legislative landscape, particularly with respect to product safety, advertising, product labeling and data privacy, the costs associated with being a public company and the market conditions for debt or equity financing.
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
RewordedRisk Factors
Although we seek to forecast and plan our product needs sufficiently in advance of anticipated requirements to facilitate reserving production time at our manufacturing and co-packing partners, and arranging for the availability and supply of packaging and ingredient materials, our product takes many weeks to arrive at our warehouses from our manufacturing partners, which reduces our flexibility to react to short term or unexpected consumer demand changes, or changes in transit times, as it can require planning as much as six months in advance to coordinate all materials for production.
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
RewordedRisk Factors
Further, by requiring that because Delaware public benefit corporate law requires boards of directors of public benefit corporations consider to balance additional constituencies other than maximizing shareholder value, Delaware and the corporation’s specified public benefit corporation law benefits, it could potentially make it easier for a board to reject a hostile bid, even where the takeover would provide bid that offers the greatest short-term financial yield to investors. investors but is inconsistent with that balancing.
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
RewordedRisk Factors
In May 2020, we entered into a five-year Our credit facility ("2020 Credit Facility") with Wells Fargo Bank, National Association, which we amended Association (the “Credit Facility”), matures in February 2030 and extended for five years on February 14, 2025, consisting consists of a revolving line of credit, which currently credit that provides for committed borrowings of $60 million.
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
RewordedRisk Factors
If we identify future deficiencies in our internal control over financial reporting or if we are unable to comply with the demands that are placed upon us as a public company, including the requirements of Section 404 of the Sarbanes-Oxley Act, in a timely manner, we may be unable to accurately report our financial results, or report them within the timeframes required by the SEC.
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
RewordedRisk Factors
Recently, there have been discussions about potential tariffs and other import related fees on goods, including those imported from China, Mexico and Canada, and while the specifics are unclear, if If tariffs or other import related fees are implemented on goods from these countries, or other countries where the Company does business, they may raise the Company's cost of importation of coconut water and require the Company to adjust its pricing or strategy.
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
RewordedRisk Factors
While we believe that we may be able to establish alternative supply relationships for some of these materials, we may be unable to do so in the short term, or at all, at prices or quality levels that are acceptable to us, or in packaging that is acceptable to consumers.
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
RewordedRisk Factors
Any such litigation could result in the impairment or loss of portions of our intellectual property, as our efforts to enforce our intellectual property rights may be met with defenses, counterclaims, and countersuits attacking the ownership, scope, validity and enforceability of our intellectual property rights.
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
RewordedRisk Factors
Any claims or litigation, even if fully indemnified or insured, could damage our reputation and potentially prevent us from selling or manufacturing our products, which would make it more difficult to compete effectively or to obtain adequate insurance in the future.
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
RewordedRisk Factors
While we continued the supply relationship for a significant portion of their private label Private Label coconut water needs in 2024 at the customer's request, in 2025, we are expecting in 2025 experienced the loss of further regions that we serviced for this customer in 2024. 2024, resulting in a decline in Private Label volume growth in 2025.
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
RewordedRisk Factors
Our Unlike traditional corporations, which have a fiduciary duty to focus exclusively on maximizing stockholder value, our directors have a fiduciary duty to consider not only our the stockholders’ interests, but also our the Company’s specific public benefit and the interests of other stakeholders affected by our actions.
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
RewordedRisk Factors
Any material disruption or slowdown of our systems or those of our third-party vendors or business partners, could have a material adverse effect on our business, financial condition, results of operations and cash flows.
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
Quiet changesRisk Factors
We believe expect that sales of our coconut water will continue to constitute a significant portion of our revenue, income and cash flow for the foreseeable future.
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
Quiet changesRisk Factors
If we are unable to manage our supply chain effectively and ensure that our products are available to meet consumer demand, we may not have the ability to pursue our growth strategy, our sales might may decrease, and our business, financial condition, results of operations and cash flows may be materially adversely affected.
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
Quiet changesRisk Factors
The success of any future acquisitions will be dependent upon our ability to effectively integrate the acquired products and operations into our business.
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
Quiet changesRisk Factors
Based upon our shares of common stock outstanding as of December 31, 2024, 2025, our executive officers, directors and shareholders who own more than 5% of our outstanding share capital, in the aggregate, beneficially own over approximately 30% of our outstanding shares of common stock.
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
AddedMD&A
Throughout 2025, we faced evolving tariff pressures, beginning with the implementation of a 10% baseline U.S. tariff and country specific rates. This was followed by reciprocal tariffs announced in August 2025 of approximately 20% for Asian countries from which we source, and incremental tariffs that raised the effective rate to 50% for Brazil. Imports from Mexico and Canada remained exempt under the United States-Mexico-Canada Agreement ("USMCA"). At the end of the third quarter of 2025, we estimated our weighted average tariff rate was 23% based on third quarter sourcing, and continued our attempts to mitigate. On November 14, 2025, the White House announced relief from the reciprocal tariffs for certain agricultural products, which included the tariff codes applicable to coconut water products, which are the bulk of our portfolio, and on November 21, 2025, a waiver on the incremental tariffs on coconut water from Brazil was announced. These November announcements significantly reduced the tariff burden on our importation of our coconut water products post November 21, 2025, although miscellaneous tariffs remain. The various tariff rates resulted in $16 million of tariffs paid in 2025.
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
AddedMD&A
Coconut water accounted for 96% of our revenue for the year ended December 31, 2025 and we believe that sales of coconut water will continue to be a significant portion of our business in the foreseeable future. The coconut water
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
AddedMD&A
Selling, General & Administrative ("SG&A") expense increased by $15.1 million, or 12.1%, primarily driven by higher personnel-related expenses of $11.0 million, increased marketing spend of $3.0 million, $1.3 million additional charitable contributions, and $1.2 million of overlapping rent expense for the New York office transition. These increases were partially offset by a $2.7 million reduction in sales-related expenses.
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
AddedMD&A
Interest income decreased by $0.2 million, to $6.5 million due to the decline in interest rates, partially offset by increased investment balances.
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
AddedMD&A
Other income of $0.2 million in the year ended December 31, 2025, resulted from the sale of intellectual property.
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
AddedMD&A
The effective tax rate for the year ended December 31, 2025 exceeded the U.S. federal statutory rate of 21% primarily due to state income taxes, and permanently nondeductible compensation costs, partially offset by tax benefits associated with windfall deductions recognized during the year. Other nondeductible expenses and discrete tax items also contributed to the higher effective tax rate.
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
AddedMD&A
We account for stock-based compensation in accordance with ASC Topic 718, Compensation—Stock Compensation ("ASC 718") for stock options issued under the 2014 Stock Option and Restricted Stock Plan and the 2021 Stock Incentive Award Plan.
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
AddedMD&A
We measure all awards based on their fair value on the date of the grant and recognize compensation expense for those awards over the requisite service period of each stock award grant, which is generally the vesting period of the respective award by using the accelerated attribution method. We apply an estimated forfeiture rate derived from historical employee termination behavior. If the actual forfeitures differ from those estimated by management, adjustment to compensation expense may be required in future periods. Stock awards are equity-classified, as they do not contain a cash settlement option or other features requiring them to be liability-classified.
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
AddedMD&A
We issue stock-based awards with service-based and performance-based and market-based vesting conditions. The accounting for performance‑based stock awards requires us to make significant judgments regarding the probability of achieving performance targets and the expected number of shares that will ultimately vest. Certain performance share unit awards allow for the issuance of shares in excess of the target award amount when performance results exceed specified thresholds. We evaluate performance expectations each reporting period and update our estimates based on current forecasts and available information. Changes in these estimates may result in adjustments to stock‑based compensation expense in future periods, which could be material to our results of operations.
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
AddedMD&A
impairment for the amount by which the carrying amount exceeds a reporting unit’s fair value. For the years ended December 31, 2025 and 2024, there were no impairments recorded.
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
RemovedMD&A
Percentage Change - Year Ended December 31, 2024 vs. 2023 Americas International Total Vita Coco Coconut Water 4.7% 12.2% 5.8% Private Label (1.9)% 12.6% 0.7% Other (10.4)% 76.3% (4.9)% Total volume (CE) 2.7% 12.8% 4.3%
Read it in 10-K Feb 26, 2025 at sec.govopen_in_new
RemovedMD&A
SG&A expense increased by $0.7 million, or 0.6%, to $125.0 million for the year ended December 31, 2024, from $124.2 million for the year ended December 31, 2023. The increased SG&A expense was primarily driven by an increase of $4.5 million in personnel-related expenses and bad debt expense of $2.2 million primarily due to the uncertainty of product delivery and repayment of advances made to a supplier. These increases were partially offset by $4.1 million lower investments in marketing expenses primarily due to inventory constraints through the third quarter of 2024, as well as the absence of a Vita Coco Community Foundation donation of $1.5 million and an impairment loss of $0.4 million related to land in Ecuador recorded in the year ended December 31, 2023.
Read it in 10-K Feb 26, 2025 at sec.govopen_in_new
RemovedMD&A
The effective tax rate for the current period is in line with the U.S. statutory rate of 21%, due to offsetting items having minimal net impact on the rate. Primarily, the benefit of lower statutory tax rates in foreign jurisdictions is offset by state income taxes. The effective tax rate for the same period in the prior year is lower than the U.S. statutory rate of 21% primarily driven by lower tax rates in foreign jurisdictions and the associated credits available to offset U.S. income tax. The change in effective tax rates between the periods is primarily attributable to state income taxes.
Read it in 10-K Feb 26, 2025 at sec.govopen_in_new
RemovedMD&A
The borrowings made prior to December 2022 bore interest at rates based on either: 1) London Interbank Offered Rate ("LIBOR"); or 2) a specified base rate (determined by reference to the greatest of the prime rate published by Wells Fargo, the federal funds effective rate plus 1.5% and one-month LIBOR plus 1.50%), as selected periodically by the Company. The LIBOR-based loans bore interest at LIBOR plus the Spread. The unused commitment fee prior to the December 2022 amendment was the same.
Read it in 10-K Feb 26, 2025 at sec.govopen_in_new
RemovedMD&A
The Jumpstart Our Business Startups Act of 2012, or the JOBS Act, permits an “emerging growth company” to take advantage of an extended transition period to comply with new or revised accounting standards applicable to public companies until those standards would otherwise apply to private companies. Following the IPO, as an emerging growth company, we elected to apply the extended transition period. Based on the closing share price and the market value of our common stock, par value $0.01 per share, held by non-affiliates as of June 30, 2023, the Company was deemed a large accelerated public company filer as of December 31, 2023. As a result, beginning with the Annual Report on Form 10-K for the year ended December 31, 2023, the Company was not able to rely on the extended transition period noted above and was required to adopt all new accounting pronouncements within the same time periods as public companies.
Read it in 10-K Feb 26, 2025 at sec.govopen_in_new
RewordedMD&A
Year Ended December 31, Change 2025 2024 2023 Amount Percentage (in thousands) (in thousands) Unrealized gain/(loss) on derivative instruments $ 4,737 $ (8,176) $ (872) $ (7,304) 12,913 n/m Foreign currency gain/(loss) loss (1,037) (1,571) (251) (1,320) 534 (34.0 Interest income, net 6,548 6,715 (167) (2.5 Other Income $ 191 $ — 191 n/m Interest income 6,715 2,581 4,134 160.2 Interest expense — (31) 31 (100.0 Other Income (Expense), Net $ 10,439 $ (3,032) $ 1,427 $ (4,459) 13,471 n/m
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
RewordedMD&A
During For the year ended December 31, 2024, 2025, we recorded an unrealized loss gain of $8.2 $4.7 million for the related to mark-to-market changes in the fair value on the outstanding derivative instruments for forward foreign currency exchange contracts, with the largest loss for the year ended December 31, 2024 gains related to the contracts hedging the Brazilian real, real and Thai baht, partially offset by gains in losses on the British Pound, Euro, and Canadian dollar.
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
RewordedMD&A
During the year ended December 31, 2024, we recorded an unrealized loss of $8.2 million for the mark-to-market changes in the fair value on the million, primarily related to outstanding derivative instruments for forward foreign currency exchange contracts, with the largest loss for the year ended December 31, 2024 related to the contracts hedging the Brazilian real, partially offset by gains in on the British Pound, Euro, and Canadian dollar.
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
RewordedMD&A
Year Ended December 31, 2025 2024 2023 (in thousands) Net income $ 71,320 $ 55,952 $ 46,629 Depreciation and amortization 1,072 745 660 Interest income income, net (6,548) (6,715) (2,581) Interest expense — 31 Income tax expense 21,651 14,836 11,291 EBITDA 87,495 64,818 56,030 Stock-based compensation (a) 10,843 8,922 9,128 Unrealized (gain)/loss on derivative instruments (b) (4,737) 8,176 872 Foreign currency (gain)/loss (b) 1,037 1,571 251 Secondary offering costs (c) — (324) 1,525 Other adjustments (d) $ 3,603 $ 964 $ 363 Adjusted EBITDA $ 98,241 $ 84,127 $ 68,169
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
RewordedMD&A
Operating activities $ 47,174 $ 42,899 $ 107,155 $ (64,256) (60.0)% 4,275 10.0% Investing activities (8,253) (974) (594) (380) 64.0% (7,279) n/m Financing activities (7,534) (8,296) 6,290 (14,586) (231.9)% 762 (9.2)% Effects of exchange rate on changes on cash and cash equivalents 834 (563) 387 (950) (245.5)% 1,397 n/m Net (decrease) increase in cash and cash equivalents $ 32,221 $ 33,066 $ 113,238 $ (80,172) (70.8)% (845) (2.6)%
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
RewordedMD&A
The increase in net sales was driven by higher coconut water CE volumes across both the Americas and International segments, including Vita Coco Coconut Water volume growth of 5.8% 21.3% and improved increased Vita Coco Coconut Water pricing due to reduced retailer promotional activity, pricing, partially offset by the transition of private label oil business. reduced Private Label water volume due to lost regions with key retailers.
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
RewordedMD&A
These increases were partially offset by a decline in private label volume due to the transition out Private Label sales in certain regions of private label oil at a key customer, and supply constraints impacting private label coconut water. retailers.
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
RewordedMD&A
In addition, Starting February 14, 2025, the Company was subject to an unused commitment fee ranging fees ranged from 0.10% 0.13% and 0.20% 0.23% on the unused amount of the line of credit in the year ended December 31, 2024, credit, with the rate being based on the Company’s leverage ratio (as defined in the credit agreement).
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
RewordedMD&A
Americas net sales increased by $12.1 $66.4 million, or 2.8%, to $442.3 million for the year ended December 31, 2024, from $430.2 million for the year ended December 31, 2023, 15.0%, primarily driven by CE volume growth of 2.7% 11.2% with additional benefit from branded pricing.
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
RewordedMD&A
The International net sales increased sales were $27.3 million, or 37.1%, driven by 33.7% CE volume growth of 12.8%, growth, with notable growth in the Europe, the Middle East United Kingdom ("U.K.") and Africa ("EMEA") region, Germany, in addition to benefits from net pricing actions.
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
RewordedMD&A
The change in both years Foreign currency loss was $1.0 million, compared to a result of $1.6 million loss for the prior year driven by movements in various foreign currency exchange rates related to on transactions denominated in currencies other than the functional currency.
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
RewordedMD&A
We Additionally, we supply private label Private Label products to key retailers in both the coconut water and coconut oil categories. categories and generate revenue from bulk product sales to beverage and food companies.
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new
Quiet changesMD&A
All forward foreign currency exchange contracts were entered into to hedge some of our exposures to the British pound, Canadian dollar, Brazilian real, Malaysian ringgit, Euro, and Thai baht.
Read it in 10-K Feb 18, 2026 at sec.govopen_in_new